Case Report: the Effect of Second-Line Vebreltinib Treatment on a Patient with Advanced NSCLC Harboring the MET Exon 14 Skipping Mutation after Tepotinib Treatment
FRONTIERS IN ONCOLOGY(2024)
Key words
vebreltinib,case report,METex14 skipping mutation,non-small cell lung cancer,treatment resistance
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined